Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
The Latest on: Alzheimer’s Disease
via Google News
The Latest on: Alzheimer’s Disease
- 2 Stocks That Could Be Winners in Alzheimer's Disease Along With Biogenon June 19, 2021 at 8:03 am
Biogen (NASDAQ: BIIB) stock skyrocketed after its Alzheimer's disease drug Aduhelm won U.S. Food and Drug Administration (FDA) approval. In this Motley Fool Live video recorded on June 9, Motley Fool ...
- 'She's not with us anymore': Ridgefield family grapples with Alzheimer's diseaseon June 19, 2021 at 7:00 am
Because there’s not a lot of understanding from my mom of what’s going on around her.” Whalen, 85, has Alzheimer’s disease and lives in her home in Ridgefield with the help of a caregiver. She can’t ...
- Unraveling the origin of Alzheimer's diseaseon June 19, 2021 at 6:54 am
Researchers studying prions -- misfolded proteins that cause lethal incurable diseases -- have identified the surface features of human prions responsible for their replication in the brain.
- KU awarded grant for minority Alzheimer’s disease researchon June 18, 2021 at 12:20 pm
The University of Kansas has been awarded a grant to research Alzheimer’s disease in minority populations, which have been underrepresented. Senator Roger Marshall (R-Kan.) says the National ...
- First insights into human prion disease could help tackle neurodegenerative diseaseson June 18, 2021 at 4:56 am
Surface features of human prions have been identified for the first time, which may provide key information into treatments of neurodegenerative diseases.
- FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's diseaseon June 18, 2021 at 12:12 am
Despite near unanimous objection from its advisory panel, the U.S. Food and Drug Administration (FDA) granted aducanumab approval to treat Alzheimer's disease on June 7, 2021. In a commentary ...
- Study finds new clues to explain how Alzheimer’s disease spreads in the brainon June 17, 2021 at 9:18 pm
Case Western Reserve University researchers studying prions-;misfolded proteins that cause lethal incurable diseases-;have identified for the first time surface features of human prions responsible ...
- Turning to Books to Grasp the Most Ungraspable Diseaseon June 17, 2021 at 4:00 pm
Sandeep Jauhar offers a tour of books about Alzheimer’s, from the search for a cure to fictionalized accounts of living with this scourge.
- What to Know About Alzheimer's Diseaseon June 17, 2021 at 4:00 pm
Here’s what to know about Alzheimer’s, a progressive disease that damages cognitive abilities. Learn about risk factors, symptoms and treatments.
via Bing News